1
Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
Condition(s):Schizophrenia; Bipolar I DisorderLast Updated:December 13, 2022Recruiting
Iloperidone as an Intervention: 29 Clinical Trials, Page 1 of 3
Hide Studies Not Open or Pending
2
Iloperidone in Mixed States of Bipolar Disorder
Condition(s):Bipolar DisorderLast Updated:February 8, 2018Completed
3
Assessing the Effects of Fanapt® on Social Cognition in Schizophrenia
Condition(s):Schizophrenia; Schizoaffective DisorderLast Updated:July 10, 2015Terminated
4
Evaluation of Efficacy and Safety of Iloperidone in the Treatment of Bipolar I Disorder
Condition(s):Bipolar I DisorderLast Updated:March 29, 2021Unknown status
5
Switching to Iloperidone From Other Antipsychotics in Schizophrenia
Condition(s):SchizophreniaLast Updated:March 15, 2013Completed
6
A Study to Evaluate Iloperidone for the Treatment of Parkinson’s Disease Psychosis
Condition(s):Parkinson Disease PsychosisLast Updated:June 3, 2022Recruiting
7
Iloperidone for Symptoms of Arousal in Post Traumatic Stress Disorder (PTSD)
Condition(s):Post Traumatic Stress DisorderLast Updated:February 11, 2020Terminated
8
Tolerability and Pharmacokinetics of Iloperidone in Adolescent Patients
Condition(s):Safety and Tolerability of IloperidoneLast Updated:June 13, 2016Completed
9
Single-dose Iloperidone Pharmacokinetics in Patients With Mild or Moderate Liver Disease, Compared to Healthy Volunteers
Condition(s):Hepatic ImpairmentLast Updated:March 14, 2013Completed
10
A Study to Evaluate Iloperidone Long-acting Injection (LAI) for the Treatment of Schizophrenia
Condition(s):SchizophreniaLast Updated:June 3, 2022Recruiting